Deep Brain Stimulation for Advanced Parkinson Disease in Developing Countries: A Cost-Effectiveness Study From China

医学 脑深部刺激 中国 帕金森病 疾病 发展中国家 物理医学与康复 神经科学 内科学 经济增长 政治学 生物 经济 法学
作者
Xinxia Guo,Feng Chen,Jiali Pu,Hongjie Jiang,Zhoule Zhu,Zhe Zheng,Jianmin Zhang,Gao Chen,Junming Zhu,Hemmings Wu
出处
期刊:Neurosurgery [Lippincott Williams & Wilkins]
卷期号:92 (4): 812-819 被引量:12
标识
DOI:10.1227/neu.0000000000002274
摘要

BACKGROUND: The cost-effectiveness of deep brain stimulation (DBS) is more favorable than best medical treatment (BMT) for advanced Parkinson disease (PD) in developed countries. However, it remains unclear in developing countries, where the cost of DBS may not be reimbursed by health care system. OBJECTIVE: To model and evaluate the long-term cost-effectiveness of DBS for advanced PD in China from a patient payer perspective. METHODS: We developed a Markov model representing the clinical progress of PD to predict the disease progression and related medical costs in a 15-year time horizon. The incremental cost-effectiveness ratio (ICER) and net benefit were used to evaluate the cost-effectiveness of DBS vs BMT. RESULTS: DBS treatment led to discounted total costs of ¥370 768 ($56 515.20) (95% CI, ¥369 621.53-371 914.88), compared with ¥48 808 ($7439.68) (95% CI, ¥48 502.63-49 114.21) for BMT, with an additional 1.51 quality-adjusted life years gained, resulting in an ICER of ¥213 544 ($32 549.96)/quality-adjusted life years (95% CI, ¥208 177.35-218 910.10). Sensitivity analysis showed that DBS-related cost has the most substantial impact on ICER. Nation-wide net benefit of BMT and DBS were ¥33 819 ($5154.94) (95% CI, ¥30 211.24-37 426) and ¥30 361 ($4627.85) (95% CI, ¥25 587.03-39 433.66), respectively. Patient demographic analysis showed that more favorable DBS cost-effectiveness was associated with younger age and less severe disease stage. CONCLUSION: DBS is cost-effective for patients with advanced PD over a 15-year time horizon in China. However, compared with developed countries, DBS remains a substantial economic burden for patients when no reimbursement is provided. Our findings may help inform cost-effectiveness-based decision making for clinical care of PD in developing countries.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SciGPT的应助被mlsun采纳,获得10
刚刚
369ninja发布了新的文献求助10
1秒前
1秒前
暮色将至发布了新的文献求助10
2秒前
2秒前
Cherry完成签到 ,获得积分10
2秒前
夹子方糖发布了新的文献求助10
2秒前
2秒前
SciGPT的应助被小蝉采纳,获得10
3秒前
tianlinghuan完成签到,获得积分10
3秒前
Akim的应助被轻松的语海采纳,获得10
3秒前
kaka1119发布了新的文献求助10
3秒前
长情老头完成签到,获得积分10
4秒前
winwin完成签到,获得积分10
4秒前
4秒前
black完成签到,获得积分10
5秒前
5秒前
6秒前
酷酷的花卷完成签到,获得积分10
7秒前
舒适的如花完成签到 ,获得积分10
7秒前
7秒前
8秒前
8秒前
831143完成签到 ,获得积分10
8秒前
8秒前
Owen的应助被lll采纳,获得10
9秒前
9秒前
10秒前
10秒前
现代的bb发布了新的文献求助10
10秒前
11秒前
12秒前
12秒前
12秒前
方剂小于发布了新的文献求助10
13秒前
13秒前
13秒前
13秒前
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184240
求助须知:如何正确求助?哪些是违规求助? 9573297
关于积分的说明 21830585
捐赠科研通 7781300
什么是DOI,文献DOI怎么找? 3434285
关于科研通互助平台的介绍 2558389
邀请新用户注册赠送积分活动 2480814